Thermo Fisher Scientific Wins LIMS Contract from University of Miami Miller School of Medicine
October 10, 2008
PHILADELPHIA, Pa. (October 10, 2008) – Thermo Fisher Scientific Inc., the world leader in serving science announced today that the University of Miami Miller School of Medicine has awarded the company a contract for its Nautilus LIMS (Laboratory Information Management System) for use in the medical school’s spinal cord injury research. During the project, scientists [...]
Invitrogen Launches Countess(TM)
October 10, 2008
Invitrogen Corporation (NASDAQ:IVGN), a provider of essential life science technologies for research, production and diagnostics, today announced the introduction of a new benchtop instrument, Countess(TM) automated cell counter, which offers a new method of automated cell counting to replace manual cell counting using a glass hemocytometer. "This instrument was designed with the scientists' workflows in [...]
Finesse Solutions Launches TruBio 3.4 Bioreactor Control Software
October 10, 2008
SANTA CLARA, Calif., Oct. 10 -- Finesse Solutions, LLC, Santa Clara, CA, a manufacturer of measurement and control solutions for life science process applications, announced the release of version 3.4 of its TruBio bioreactor control software. TruBio 3.4 software can automate bioreactors across a wide variety of applications, ranging from 1L bench top R&D glass [...]
University of Miami Miller School of Medicine LIMS Contract
October 10, 2008
PHILADELPHIA, Pa. (October 10, 2008) - Thermo Fisher Scientific Inc., the world leader in serving science announced today that the University of Miami Miller School of Medicine has awarded the company a contract for its Nautilus LIMS (Laboratory Information Management System) for use in the medical school’s spinal cord injury research. During the project, scientists [...]
October 9, 2008
Invitrogen Corporation (NASDAQ:IVGN) today announced that the company has completed a significant milestone in the integration planning for the Applied Biosystems combination. The company has finalized the synergy targets by identifying specific actions and timing to achieve the synergies for all functions within the new company. "The synergy work we've had underway for the last [...]
October 9, 2008
9 October 2008: Malvern, UK: Malvern’s new Zetasizer µV is an advanced light scattering system specifically intended for the characterization of proteins and other biomolecules. This latest addition to Malvern’s highly successful Zetasizer family, is designed and optimised for maximum sensitivity and minimum sample volume. The Zetasizer µV is a dedicated system that supports improved [...]
October 9, 2008
Agilent Technologies Inc. (NYSE:A) today announced that the Turku Centre for Biotechnology of University of Turku and Abo Akademi University has achieved Certified Service Provider status for Agilent gene expression microarrays. The Centre achieved Agilent-certified status after completing training and passing a rigorous series of assessments that include: -- demonstrating proficiency in analyzing Agilent's 60-mer [...]
October 9, 2008
SAN DIEGO--Accelrys, Inc. (NASDAQ: ACCL - News), a leading provider of scientific business intelligence software and services, today announced that one of the largest multi-national oil and gas companies has chosen Accelrys to develop an integrated solution which would enable this company’s catalyst research scientists to both accelerate catalysis research and discovery and to improve [...]
Illumina Launches mRNA-Seq on the Genome Analyzer
October 9, 2008
Illumina, Inc. (NASDAQ:ILMN) today announced the broad availability of mRNA-Seq, a new product for full-length, complementary DNA (cDNA) sequencing on the Genome Analyzer. In contrast to tiling and exon arrays, researchers can use mRNA-Seq to obtain a more in-depth, comprehensive view of the transcriptome, revealing aspects previously unseen using array-based or expression sequence tag (EST) [...]
October 9, 2008
Roche NimbleGen, a company of Roche announced today the launch of comparative genomic hybridization (CGH) arrays and services for the high-resolution mapping of genomic copy-number differences based on the company's new 2.1 million-probe HD2 platform. Roche NimbleGen's HD2 array platform greatly enhances the capability and resolution of CGH whole-genome analysis by providing a single array [...]

